nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP11A1—Cholecalciferol—psoriasis	0.127	0.169	CbGbCtD
Clomifene—CYP1A1—Clobetasol propionate—psoriasis	0.0917	0.122	CbGbCtD
Clomifene—CYP2A6—Methoxsalen—psoriasis	0.0564	0.0752	CbGbCtD
Clomifene—CYP11A1—Dexamethasone—psoriasis	0.0548	0.0731	CbGbCtD
Clomifene—CYP1A1—Methoxsalen—psoriasis	0.0482	0.0643	CbGbCtD
Clomifene—CYP19A1—Betamethasone—psoriasis	0.0439	0.0585	CbGbCtD
Clomifene—CYP1A2—Clobetasol propionate—psoriasis	0.041	0.0546	CbGbCtD
Clomifene—CYP1A1—Cholecalciferol—psoriasis	0.0319	0.0426	CbGbCtD
Clomifene—CYP2A6—Prednisolone—psoriasis	0.0274	0.0366	CbGbCtD
Clomifene—CYP19A1—Dexamethasone—psoriasis	0.0255	0.034	CbGbCtD
Clomifene—CYP1A2—Methoxsalen—psoriasis	0.0215	0.0287	CbGbCtD
Clomifene—CYP2A6—Dexamethasone—psoriasis	0.0162	0.0216	CbGbCtD
Clomifene—CYP3A4—Calcitriol—psoriasis	0.0145	0.0193	CbGbCtD
Clomifene—CYP1A1—Dexamethasone—psoriasis	0.0138	0.0184	CbGbCtD
Clomifene—CYP3A4—Methoxsalen—psoriasis	0.0113	0.015	CbGbCtD
Clomifene—ABCB1—Mycophenolate mofetil—psoriasis	0.0108	0.0144	CbGbCtD
Clomifene—CYP2E1—Dexamethasone—psoriasis	0.0107	0.0142	CbGbCtD
Clomifene—ABCB1—Betamethasone—psoriasis	0.00927	0.0124	CbGbCtD
Clomifene—ABCB1—Prednisolone—psoriasis	0.00915	0.0122	CbGbCtD
Clomifene—ABCB1—Hydrocortisone—psoriasis	0.00868	0.0116	CbGbCtD
Clomifene—ABCB1—Prednisone—psoriasis	0.00864	0.0115	CbGbCtD
Clomifene—ABCB1—Cyclosporine—psoriasis	0.00819	0.0109	CbGbCtD
Clomifene—CYP3A4—Cholecalciferol—psoriasis	0.00747	0.00996	CbGbCtD
Clomifene—CYP3A4—Mycophenolate mofetil—psoriasis	0.00648	0.00864	CbGbCtD
Clomifene—CYP3A4—Triamcinolone—psoriasis	0.00648	0.00864	CbGbCtD
Clomifene—CYP3A4—Betamethasone—psoriasis	0.00556	0.00741	CbGbCtD
Clomifene—CYP3A4—Prednisolone—psoriasis	0.00548	0.00731	CbGbCtD
Clomifene—ABCB1—Dexamethasone—psoriasis	0.00539	0.00719	CbGbCtD
Clomifene—CYP3A4—Hydrocortisone—psoriasis	0.0052	0.00693	CbGbCtD
Clomifene—CYP3A4—Prednisone—psoriasis	0.00518	0.00691	CbGbCtD
Clomifene—CYP3A4—Cyclosporine—psoriasis	0.00491	0.00655	CbGbCtD
Clomifene—ABCB1—Methotrexate—psoriasis	0.00434	0.00578	CbGbCtD
Clomifene—CYP3A4—Dexamethasone—psoriasis	0.00323	0.00431	CbGbCtD
Clomifene—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.000855	1	CbGdCrCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000287	0.00584	CbGpPWpGaD
Clomifene—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000272	0.00553	CbGpPWpGaD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000262	0.00533	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000257	0.00523	CbGpPWpGaD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000252	0.00513	CbGpPWpGaD
Clomifene—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000246	0.005	CbGpPWpGaD
Clomifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000243	0.00494	CbGpPWpGaD
Clomifene—EBP—Metabolism—NDUFA5—psoriasis	0.00024	0.00487	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000238	0.00483	CbGpPWpGaD
Clomifene—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000236	0.00479	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000233	0.00473	CbGpPWpGaD
Clomifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000231	0.00471	CbGpPWpGaD
Clomifene—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000231	0.00469	CbGpPWpGaD
Clomifene—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000229	0.00466	CbGpPWpGaD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000229	0.00465	CbGpPWpGaD
Clomifene—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000228	0.00464	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000226	0.00459	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000224	0.00454	CbGpPWpGaD
Clomifene—ESR1—Estrogen signaling pathway—JUN—psoriasis	0.00022	0.00448	CbGpPWpGaD
Clomifene—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000215	0.00437	CbGpPWpGaD
Clomifene—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	0.000212	0.00431	CbGpPWpGaD
Clomifene—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000212	0.00431	CbGpPWpGaD
Clomifene—ESR1—Nuclear Receptors—PPARG—psoriasis	0.000208	0.00423	CbGpPWpGaD
Clomifene—EBP—Metabolism—CYP2S1—psoriasis	0.000204	0.00414	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000203	0.00412	CbGpPWpGaD
Clomifene—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.0002	0.00406	CbGpPWpGaD
Clomifene—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000199	0.00405	CbGpPWpGaD
Clomifene—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000196	0.00399	CbGpPWpGaD
Clomifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000188	0.00381	CbGpPWpGaD
Clomifene—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000185	0.00377	CbGpPWpGaD
Clomifene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000185	0.00376	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000185	0.00376	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000179	0.00363	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000178	0.00362	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL10—psoriasis	0.000178	0.00362	CbGpPWpGaD
Clomifene—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000175	0.00355	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000175	0.00355	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL4—psoriasis	0.000173	0.00352	CbGpPWpGaD
Clomifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000173	0.00351	CbGpPWpGaD
Clomifene—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000164	0.00334	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	0.000163	0.00331	CbGpPWpGaD
Clomifene—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00016	0.00325	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	0.000158	0.00322	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000158	0.0032	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	0.000157	0.00319	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	0.000157	0.00318	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000151	0.00308	CbGpPWpGaD
Clomifene—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000147	0.00299	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000146	0.00296	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000144	0.00293	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000141	0.00288	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—LEP—psoriasis	0.000139	0.00282	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000138	0.00281	CbGpPWpGaD
Clomifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000138	0.0028	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000138	0.0028	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL13—psoriasis	0.000137	0.00278	CbGpPWpGaD
Clomifene—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.000133	0.0027	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000132	0.00268	CbGpPWpGaD
Clomifene—ESR1—FOXA1 transcription factor network—JUN—psoriasis	0.000131	0.00267	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000129	0.00263	CbGpPWpGaD
Clomifene—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000127	0.00259	CbGpPWpGaD
Clomifene—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000127	0.00258	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000126	0.00256	CbGpPWpGaD
Clomifene—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000125	0.00255	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000122	0.00248	CbGpPWpGaD
Clomifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00012	0.00245	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	0.00012	0.00244	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000118	0.0024	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000117	0.00238	CbGpPWpGaD
Clomifene—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000117	0.00237	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000114	0.00232	CbGpPWpGaD
Clomifene—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000114	0.00231	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	0.000112	0.00227	CbGpPWpGaD
Clomifene—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000111	0.00227	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000111	0.00225	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—IFNG—psoriasis	0.000107	0.00218	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000107	0.00217	CbGpPWpGaD
Clomifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000106	0.00216	CbGpPWpGaD
Clomifene—Loss of consciousness—Prednisolone—psoriasis	0.000105	0.000524	CcSEcCtD
Clomifene—Vertigo—Hydrocortisone—psoriasis	0.000105	0.000523	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—IFNG—psoriasis	0.000105	0.00213	CbGpPWpGaD
Clomifene—Body temperature increased—Mycophenolic acid—psoriasis	0.000105	0.000523	CcSEcCtD
Clomifene—Syncope—Hydrocortisone—psoriasis	0.000105	0.000522	CcSEcCtD
Clomifene—Dizziness—Hydroxyurea—psoriasis	0.000104	0.000522	CcSEcCtD
Clomifene—Oedema—Mycophenolate mofetil—psoriasis	0.000104	0.000522	CcSEcCtD
Clomifene—ESR1—Gene Expression—TARS—psoriasis	0.000104	0.00212	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000104	0.00211	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—JUN—psoriasis	0.000104	0.00211	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—NDUFA5—psoriasis	0.000104	0.00211	CbGpPWpGaD
Clomifene—Convulsion—Prednisolone—psoriasis	0.000103	0.000517	CcSEcCtD
Clomifene—Hypertension—Prednisolone—psoriasis	0.000103	0.000515	CcSEcCtD
Clomifene—Shock—Mycophenolate mofetil—psoriasis	0.000103	0.000513	CcSEcCtD
Clomifene—Loss of consciousness—Hydrocortisone—psoriasis	0.000102	0.000512	CcSEcCtD
Clomifene—Arrhythmia—Dexamethasone—psoriasis	0.000102	0.000511	CcSEcCtD
Clomifene—Arrhythmia—Betamethasone—psoriasis	0.000102	0.000511	CcSEcCtD
Clomifene—Pancreatitis—Methotrexate—psoriasis	0.000102	0.00051	CcSEcCtD
Clomifene—Tachycardia—Mycophenolate mofetil—psoriasis	0.000102	0.000509	CcSEcCtD
Clomifene—Alopecia—Betamethasone—psoriasis	0.000101	0.000505	CcSEcCtD
Clomifene—Alopecia—Dexamethasone—psoriasis	0.000101	0.000505	CcSEcCtD
Clomifene—Convulsion—Hydrocortisone—psoriasis	0.000101	0.000505	CcSEcCtD
Clomifene—Hypertension—Hydrocortisone—psoriasis	0.000101	0.000503	CcSEcCtD
Clomifene—Vomiting—Hydroxyurea—psoriasis	0.0001	0.000502	CcSEcCtD
Clomifene—Abdominal discomfort—Methotrexate—psoriasis	9.97e-05	0.000498	CcSEcCtD
Clomifene—CYP3A4—Biological oxidations—CYP2S1—psoriasis	9.97e-05	0.00203	CbGpPWpGaD
Clomifene—Rash—Hydroxyurea—psoriasis	9.96e-05	0.000498	CcSEcCtD
Clomifene—Erythema—Betamethasone—psoriasis	9.96e-05	0.000498	CcSEcCtD
Clomifene—Erythema—Dexamethasone—psoriasis	9.96e-05	0.000498	CcSEcCtD
Clomifene—EBP—Metabolism—CARM1—psoriasis	9.95e-05	0.00202	CbGpPWpGaD
Clomifene—Dermatitis—Hydroxyurea—psoriasis	9.95e-05	0.000497	CcSEcCtD
Clomifene—Myalgia—Hydrocortisone—psoriasis	9.93e-05	0.000496	CcSEcCtD
Clomifene—Headache—Hydroxyurea—psoriasis	9.9e-05	0.000495	CcSEcCtD
Clomifene—Anxiety—Hydrocortisone—psoriasis	9.89e-05	0.000494	CcSEcCtD
Clomifene—Vertigo—Triamcinolone—psoriasis	9.86e-05	0.000493	CcSEcCtD
Clomifene—Syncope—Triamcinolone—psoriasis	9.84e-05	0.000492	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	9.83e-05	0.002	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Cyclosporine—psoriasis	9.75e-05	0.000487	CcSEcCtD
Clomifene—Oedema—Prednisolone—psoriasis	9.74e-05	0.000487	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	9.73e-05	0.00198	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	9.72e-05	0.00198	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	9.7e-05	0.00197	CbGpPWpGaD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	9.69e-05	0.00197	CbGpPWpGaD
Clomifene—Insomnia—Cyclosporine—psoriasis	9.68e-05	0.000484	CcSEcCtD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.67e-05	0.00197	CbGpPWpGaD
Clomifene—Loss of consciousness—Triamcinolone—psoriasis	9.65e-05	0.000482	CcSEcCtD
Clomifene—Paraesthesia—Cyclosporine—psoriasis	9.61e-05	0.00048	CcSEcCtD
Clomifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.6e-05	0.00195	CbGpPWpGaD
Clomifene—Shock—Prednisolone—psoriasis	9.58e-05	0.000479	CcSEcCtD
Clomifene—Dyspnoea—Cyclosporine—psoriasis	9.54e-05	0.000477	CcSEcCtD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	9.54e-05	0.00194	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	9.51e-05	0.000476	CcSEcCtD
Clomifene—Oedema—Hydrocortisone—psoriasis	9.51e-05	0.000475	CcSEcCtD
Clomifene—Convulsion—Triamcinolone—psoriasis	9.51e-05	0.000475	CcSEcCtD
Clomifene—Tachycardia—Prednisolone—psoriasis	9.51e-05	0.000475	CcSEcCtD
Clomifene—Asthenia—Mycophenolic acid—psoriasis	9.49e-05	0.000475	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.48e-05	0.00193	CbGpPWpGaD
Clomifene—Hypertension—Triamcinolone—psoriasis	9.48e-05	0.000474	CcSEcCtD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	9.45e-05	0.00192	CbGpPWpGaD
Clomifene—Insomnia—Mycophenolate mofetil—psoriasis	9.45e-05	0.000472	CcSEcCtD
Clomifene—Nausea—Hydroxyurea—psoriasis	9.39e-05	0.000469	CcSEcCtD
Clomifene—Paraesthesia—Mycophenolate mofetil—psoriasis	9.38e-05	0.000469	CcSEcCtD
Clomifene—Pruritus—Mycophenolic acid—psoriasis	9.36e-05	0.000468	CcSEcCtD
Clomifene—Shock—Hydrocortisone—psoriasis	9.36e-05	0.000468	CcSEcCtD
Clomifene—Myalgia—Triamcinolone—psoriasis	9.35e-05	0.000467	CcSEcCtD
Clomifene—Dyspnoea—Mycophenolate mofetil—psoriasis	9.31e-05	0.000465	CcSEcCtD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.3e-05	0.00189	CbGpPWpGaD
Clomifene—Tachycardia—Hydrocortisone—psoriasis	9.29e-05	0.000464	CcSEcCtD
Clomifene—ESR1—Regulation of Telomerase—JUN—psoriasis	9.26e-05	0.00188	CbGpPWpGaD
Clomifene—Flushing—Prednisone—psoriasis	9.25e-05	0.000462	CcSEcCtD
Clomifene—Fatigue—Cyclosporine—psoriasis	9.23e-05	0.000461	CcSEcCtD
Clomifene—Pain—Cyclosporine—psoriasis	9.16e-05	0.000458	CcSEcCtD
Clomifene—Constipation—Cyclosporine—psoriasis	9.16e-05	0.000458	CcSEcCtD
Clomifene—Renal failure—Methotrexate—psoriasis	9.12e-05	0.000456	CcSEcCtD
Clomifene—Diarrhoea—Mycophenolic acid—psoriasis	9.05e-05	0.000453	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—JUN—psoriasis	9.05e-05	0.00184	CbGpPWpGaD
Clomifene—Oedema—Triamcinolone—psoriasis	8.96e-05	0.000448	CcSEcCtD
Clomifene—Vertigo—Dexamethasone—psoriasis	8.95e-05	0.000447	CcSEcCtD
Clomifene—Vertigo—Betamethasone—psoriasis	8.95e-05	0.000447	CcSEcCtD
Clomifene—Syncope—Betamethasone—psoriasis	8.93e-05	0.000446	CcSEcCtD
Clomifene—Syncope—Dexamethasone—psoriasis	8.93e-05	0.000446	CcSEcCtD
Clomifene—Constipation—Mycophenolate mofetil—psoriasis	8.93e-05	0.000446	CcSEcCtD
Clomifene—Pain—Mycophenolate mofetil—psoriasis	8.93e-05	0.000446	CcSEcCtD
Clomifene—ESR1—Regulation of Telomerase—NFKB1—psoriasis	8.92e-05	0.00181	CbGpPWpGaD
Clomifene—Arrhythmia—Prednisone—psoriasis	8.9e-05	0.000445	CcSEcCtD
Clomifene—ESR1—LKB1 signaling events—TP53—psoriasis	8.82e-05	0.00179	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CYP2S1—psoriasis	8.82e-05	0.00179	CbGpPWpGaD
Clomifene—Shock—Triamcinolone—psoriasis	8.81e-05	0.00044	CcSEcCtD
Clomifene—Insomnia—Prednisolone—psoriasis	8.81e-05	0.00044	CcSEcCtD
Clomifene—Alopecia—Prednisone—psoriasis	8.81e-05	0.00044	CcSEcCtD
Clomifene—Loss of consciousness—Dexamethasone—psoriasis	8.75e-05	0.000437	CcSEcCtD
Clomifene—Loss of consciousness—Betamethasone—psoriasis	8.75e-05	0.000437	CcSEcCtD
Clomifene—Dizziness—Mycophenolic acid—psoriasis	8.75e-05	0.000437	CcSEcCtD
Clomifene—Paraesthesia—Prednisolone—psoriasis	8.75e-05	0.000437	CcSEcCtD
Clomifene—Tachycardia—Triamcinolone—psoriasis	8.74e-05	0.000437	CcSEcCtD
Clomifene—Erythema—Prednisone—psoriasis	8.67e-05	0.000433	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.67e-05	0.000433	CcSEcCtD
Clomifene—Convulsion—Betamethasone—psoriasis	8.63e-05	0.000431	CcSEcCtD
Clomifene—Convulsion—Dexamethasone—psoriasis	8.63e-05	0.000431	CcSEcCtD
Clomifene—Insomnia—Hydrocortisone—psoriasis	8.61e-05	0.00043	CcSEcCtD
Clomifene—Hypertension—Dexamethasone—psoriasis	8.6e-05	0.00043	CcSEcCtD
Clomifene—Hypertension—Betamethasone—psoriasis	8.6e-05	0.00043	CcSEcCtD
Clomifene—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.6e-05	0.00175	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL10—psoriasis	8.55e-05	0.00174	CbGpPWpGaD
Clomifene—Paraesthesia—Hydrocortisone—psoriasis	8.54e-05	0.000427	CcSEcCtD
Clomifene—Urticaria—Cyclosporine—psoriasis	8.5e-05	0.000425	CcSEcCtD
Clomifene—Myalgia—Betamethasone—psoriasis	8.48e-05	0.000424	CcSEcCtD
Clomifene—Myalgia—Dexamethasone—psoriasis	8.48e-05	0.000424	CcSEcCtD
Clomifene—Body temperature increased—Cyclosporine—psoriasis	8.46e-05	0.000423	CcSEcCtD
Clomifene—Anxiety—Dexamethasone—psoriasis	8.45e-05	0.000422	CcSEcCtD
Clomifene—Anxiety—Betamethasone—psoriasis	8.45e-05	0.000422	CcSEcCtD
Clomifene—Vomiting—Mycophenolic acid—psoriasis	8.41e-05	0.00042	CcSEcCtD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	8.39e-05	0.00171	CbGpPWpGaD
Clomifene—Rash—Mycophenolic acid—psoriasis	8.34e-05	0.000417	CcSEcCtD
Clomifene—Dermatitis—Mycophenolic acid—psoriasis	8.34e-05	0.000417	CcSEcCtD
Clomifene—Pain—Prednisolone—psoriasis	8.33e-05	0.000416	CcSEcCtD
Clomifene—Hepatitis—Methotrexate—psoriasis	8.33e-05	0.000416	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—IL4—psoriasis	8.32e-05	0.00169	CbGpPWpGaD
Clomifene—Urticaria—Mycophenolate mofetil—psoriasis	8.3e-05	0.000415	CcSEcCtD
Clomifene—Headache—Mycophenolic acid—psoriasis	8.29e-05	0.000414	CcSEcCtD
Clomifene—Body temperature increased—Mycophenolate mofetil—psoriasis	8.26e-05	0.000413	CcSEcCtD
Clomifene—ESR1—Leptin signaling pathway—NFKB1—psoriasis	8.24e-05	0.00168	CbGpPWpGaD
Clomifene—Fatigue—Hydrocortisone—psoriasis	8.2e-05	0.00041	CcSEcCtD
Clomifene—Vision blurred—Prednisone—psoriasis	8.17e-05	0.000409	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.16e-05	0.000408	CcSEcCtD
Clomifene—Pain—Hydrocortisone—psoriasis	8.14e-05	0.000407	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—HLA-B—psoriasis	8.13e-05	0.00165	CbGpPWpGaD
Clomifene—Oedema—Betamethasone—psoriasis	8.13e-05	0.000406	CcSEcCtD
Clomifene—Oedema—Dexamethasone—psoriasis	8.13e-05	0.000406	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	8.12e-05	0.00165	CbGpPWpGaD
Clomifene—Insomnia—Triamcinolone—psoriasis	8.1e-05	0.000405	CcSEcCtD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	8.07e-05	0.00164	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	8.05e-05	0.00164	CbGpPWpGaD
Clomifene—Paraesthesia—Triamcinolone—psoriasis	8.04e-05	0.000402	CcSEcCtD
Clomifene—Visual impairment—Methotrexate—psoriasis	8.03e-05	0.000401	CcSEcCtD
Clomifene—Shock—Dexamethasone—psoriasis	8e-05	0.0004	CcSEcCtD
Clomifene—Shock—Betamethasone—psoriasis	8e-05	0.0004	CcSEcCtD
Clomifene—Dyspnoea—Triamcinolone—psoriasis	7.99e-05	0.000399	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	7.96e-05	0.00162	CbGpPWpGaD
Clomifene—Tachycardia—Betamethasone—psoriasis	7.93e-05	0.000396	CcSEcCtD
Clomifene—Tachycardia—Dexamethasone—psoriasis	7.93e-05	0.000396	CcSEcCtD
Clomifene—Hypersensitivity—Cyclosporine—psoriasis	7.89e-05	0.000394	CcSEcCtD
Clomifene—Erythema multiforme—Methotrexate—psoriasis	7.87e-05	0.000393	CcSEcCtD
Clomifene—Nausea—Mycophenolic acid—psoriasis	7.86e-05	0.000393	CcSEcCtD
Clomifene—Vertigo—Prednisone—psoriasis	7.79e-05	0.000389	CcSEcCtD
Clomifene—Syncope—Prednisone—psoriasis	7.78e-05	0.000389	CcSEcCtD
Clomifene—Tinnitus—Methotrexate—psoriasis	7.76e-05	0.000388	CcSEcCtD
Clomifene—Urticaria—Prednisolone—psoriasis	7.74e-05	0.000387	CcSEcCtD
Clomifene—Fatigue—Triamcinolone—psoriasis	7.72e-05	0.000386	CcSEcCtD
Clomifene—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.69e-05	0.000385	CcSEcCtD
Clomifene—Asthenia—Cyclosporine—psoriasis	7.68e-05	0.000384	CcSEcCtD
Clomifene—Pain—Triamcinolone—psoriasis	7.66e-05	0.000383	CcSEcCtD
Clomifene—Loss of consciousness—Prednisone—psoriasis	7.62e-05	0.000381	CcSEcCtD
Clomifene—Pruritus—Cyclosporine—psoriasis	7.57e-05	0.000379	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	7.57e-05	0.00154	CbGpPWpGaD
Clomifene—Urticaria—Hydrocortisone—psoriasis	7.56e-05	0.000378	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—HLA-A—psoriasis	7.54e-05	0.00153	CbGpPWpGaD
Clomifene—Body temperature increased—Hydrocortisone—psoriasis	7.52e-05	0.000376	CcSEcCtD
Clomifene—Convulsion—Prednisone—psoriasis	7.52e-05	0.000376	CcSEcCtD
Clomifene—Asthenia—Mycophenolate mofetil—psoriasis	7.49e-05	0.000374	CcSEcCtD
Clomifene—Hypertension—Prednisone—psoriasis	7.49e-05	0.000374	CcSEcCtD
Clomifene—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	7.45e-05	0.00151	CbGpPWpGaD
Clomifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.41e-05	0.00151	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—STAT3—psoriasis	7.41e-05	0.00151	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Betamethasone—psoriasis	7.41e-05	0.00037	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.41e-05	0.00037	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	7.4e-05	0.0015	CbGpPWpGaD
Clomifene—Pruritus—Mycophenolate mofetil—psoriasis	7.39e-05	0.000369	CcSEcCtD
Clomifene—Myalgia—Prednisone—psoriasis	7.38e-05	0.000369	CcSEcCtD
Clomifene—Arthralgia—Prednisone—psoriasis	7.38e-05	0.000369	CcSEcCtD
Clomifene—Anxiety—Prednisone—psoriasis	7.36e-05	0.000368	CcSEcCtD
Clomifene—Alopecia—Methotrexate—psoriasis	7.36e-05	0.000368	CcSEcCtD
Clomifene—Insomnia—Betamethasone—psoriasis	7.35e-05	0.000367	CcSEcCtD
Clomifene—Insomnia—Dexamethasone—psoriasis	7.35e-05	0.000367	CcSEcCtD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	7.33e-05	0.00149	CbGpPWpGaD
Clomifene—Diarrhoea—Cyclosporine—psoriasis	7.33e-05	0.000366	CcSEcCtD
Clomifene—Paraesthesia—Betamethasone—psoriasis	7.3e-05	0.000365	CcSEcCtD
Clomifene—Paraesthesia—Dexamethasone—psoriasis	7.3e-05	0.000365	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.28e-05	0.00148	CbGpPWpGaD
Clomifene—Erythema—Methotrexate—psoriasis	7.25e-05	0.000362	CcSEcCtD
Clomifene—Hypersensitivity—Prednisolone—psoriasis	7.18e-05	0.000359	CcSEcCtD
Clomifene—Diarrhoea—Mycophenolate mofetil—psoriasis	7.15e-05	0.000357	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.12e-05	0.00145	CbGpPWpGaD
Clomifene—Urticaria—Triamcinolone—psoriasis	7.12e-05	0.000356	CcSEcCtD
Clomifene—Body temperature increased—Triamcinolone—psoriasis	7.08e-05	0.000354	CcSEcCtD
Clomifene—Dizziness—Cyclosporine—psoriasis	7.08e-05	0.000354	CcSEcCtD
Clomifene—Oedema—Prednisone—psoriasis	7.08e-05	0.000354	CcSEcCtD
Clomifene—Back pain—Methotrexate—psoriasis	7.01e-05	0.00035	CcSEcCtD
Clomifene—Hypersensitivity—Hydrocortisone—psoriasis	7.01e-05	0.00035	CcSEcCtD
Clomifene—Fatigue—Dexamethasone—psoriasis	7.01e-05	0.00035	CcSEcCtD
Clomifene—Fatigue—Betamethasone—psoriasis	7.01e-05	0.00035	CcSEcCtD
Clomifene—Shock—Prednisone—psoriasis	6.96e-05	0.000348	CcSEcCtD
Clomifene—Pain—Betamethasone—psoriasis	6.95e-05	0.000347	CcSEcCtD
Clomifene—Pain—Dexamethasone—psoriasis	6.95e-05	0.000347	CcSEcCtD
Clomifene—Tachycardia—Prednisone—psoriasis	6.91e-05	0.000345	CcSEcCtD
Clomifene—Dizziness—Mycophenolate mofetil—psoriasis	6.91e-05	0.000345	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	6.89e-05	0.0014	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—NDUFA5—psoriasis	6.87e-05	0.0014	CbGpPWpGaD
Clomifene—Vision blurred—Methotrexate—psoriasis	6.83e-05	0.000341	CcSEcCtD
Clomifene—Asthenia—Hydrocortisone—psoriasis	6.83e-05	0.000341	CcSEcCtD
Clomifene—ESR1—Generic Transcription Pathway—CARM1—psoriasis	6.82e-05	0.00139	CbGpPWpGaD
Clomifene—Vomiting—Cyclosporine—psoriasis	6.81e-05	0.00034	CcSEcCtD
Clomifene—Rash—Cyclosporine—psoriasis	6.75e-05	0.000337	CcSEcCtD
Clomifene—Dermatitis—Cyclosporine—psoriasis	6.74e-05	0.000337	CcSEcCtD
Clomifene—Pruritus—Hydrocortisone—psoriasis	6.73e-05	0.000336	CcSEcCtD
Clomifene—Headache—Cyclosporine—psoriasis	6.71e-05	0.000335	CcSEcCtD
Clomifene—Vomiting—Mycophenolate mofetil—psoriasis	6.64e-05	0.000332	CcSEcCtD
Clomifene—Hypersensitivity—Triamcinolone—psoriasis	6.6e-05	0.00033	CcSEcCtD
Clomifene—Rash—Mycophenolate mofetil—psoriasis	6.58e-05	0.000329	CcSEcCtD
Clomifene—Dermatitis—Mycophenolate mofetil—psoriasis	6.58e-05	0.000329	CcSEcCtD
Clomifene—Headache—Mycophenolate mofetil—psoriasis	6.54e-05	0.000327	CcSEcCtD
Clomifene—Vertigo—Methotrexate—psoriasis	6.51e-05	0.000325	CcSEcCtD
Clomifene—Diarrhoea—Hydrocortisone—psoriasis	6.51e-05	0.000325	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.46e-05	0.00131	CbGpPWpGaD
Clomifene—Urticaria—Dexamethasone—psoriasis	6.46e-05	0.000323	CcSEcCtD
Clomifene—Urticaria—Betamethasone—psoriasis	6.46e-05	0.000323	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Prednisone—psoriasis	6.45e-05	0.000322	CcSEcCtD
Clomifene—Dizziness—Prednisolone—psoriasis	6.44e-05	0.000322	CcSEcCtD
Clomifene—Asthenia—Triamcinolone—psoriasis	6.43e-05	0.000321	CcSEcCtD
Clomifene—Body temperature increased—Dexamethasone—psoriasis	6.43e-05	0.000321	CcSEcCtD
Clomifene—Body temperature increased—Betamethasone—psoriasis	6.43e-05	0.000321	CcSEcCtD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.4e-05	0.0013	CbGpPWpGaD
Clomifene—Insomnia—Prednisone—psoriasis	6.4e-05	0.00032	CcSEcCtD
Clomifene—Nausea—Cyclosporine—psoriasis	6.36e-05	0.000318	CcSEcCtD
Clomifene—Paraesthesia—Prednisone—psoriasis	6.36e-05	0.000318	CcSEcCtD
Clomifene—Pruritus—Triamcinolone—psoriasis	6.34e-05	0.000317	CcSEcCtD
Clomifene—Dizziness—Hydrocortisone—psoriasis	6.29e-05	0.000314	CcSEcCtD
Clomifene—Convulsion—Methotrexate—psoriasis	6.28e-05	0.000314	CcSEcCtD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.28e-05	0.00128	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	6.28e-05	0.00128	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—IL6—psoriasis	6.27e-05	0.00127	CbGpPWpGaD
Clomifene—Nausea—Mycophenolate mofetil—psoriasis	6.2e-05	0.00031	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.19e-05	0.00126	CbGpPWpGaD
Clomifene—Chest pain—Methotrexate—psoriasis	6.17e-05	0.000308	CcSEcCtD
Clomifene—Arthralgia—Methotrexate—psoriasis	6.17e-05	0.000308	CcSEcCtD
Clomifene—Myalgia—Methotrexate—psoriasis	6.17e-05	0.000308	CcSEcCtD
Clomifene—Rash—Prednisolone—psoriasis	6.14e-05	0.000307	CcSEcCtD
Clomifene—Dermatitis—Prednisolone—psoriasis	6.14e-05	0.000307	CcSEcCtD
Clomifene—EBP—Metabolism—CAT—psoriasis	6.12e-05	0.00124	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.12e-05	0.00124	CbGpPWpGaD
Clomifene—Fatigue—Prednisone—psoriasis	6.1e-05	0.000305	CcSEcCtD
Clomifene—Headache—Prednisolone—psoriasis	6.1e-05	0.000305	CcSEcCtD
Clomifene—Constipation—Prednisone—psoriasis	6.05e-05	0.000303	CcSEcCtD
Clomifene—Vomiting—Hydrocortisone—psoriasis	6.05e-05	0.000302	CcSEcCtD
Clomifene—ESR1—Signaling by ERBB4—TYK2—psoriasis	6.01e-05	0.00122	CbGpPWpGaD
Clomifene—Rash—Hydrocortisone—psoriasis	6e-05	0.0003	CcSEcCtD
Clomifene—Dermatitis—Hydrocortisone—psoriasis	5.99e-05	0.0003	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—TP53—psoriasis	5.97e-05	0.00121	CbGpPWpGaD
Clomifene—Headache—Hydrocortisone—psoriasis	5.96e-05	0.000298	CcSEcCtD
Clomifene—Dizziness—Triamcinolone—psoriasis	5.92e-05	0.000296	CcSEcCtD
Clomifene—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	5.89e-05	0.0012	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP2S1—psoriasis	5.84e-05	0.00119	CbGpPWpGaD
Clomifene—Asthenia—Betamethasone—psoriasis	5.83e-05	0.000291	CcSEcCtD
Clomifene—Asthenia—Dexamethasone—psoriasis	5.83e-05	0.000291	CcSEcCtD
Clomifene—Nausea—Prednisolone—psoriasis	5.79e-05	0.000289	CcSEcCtD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	5.76e-05	0.00117	CbGpPWpGaD
Clomifene—Pruritus—Betamethasone—psoriasis	5.75e-05	0.000287	CcSEcCtD
Clomifene—Pruritus—Dexamethasone—psoriasis	5.75e-05	0.000287	CcSEcCtD
Clomifene—Vomiting—Triamcinolone—psoriasis	5.7e-05	0.000285	CcSEcCtD
Clomifene—Nausea—Hydrocortisone—psoriasis	5.65e-05	0.000282	CcSEcCtD
Clomifene—Rash—Triamcinolone—psoriasis	5.65e-05	0.000282	CcSEcCtD
Clomifene—Dermatitis—Triamcinolone—psoriasis	5.64e-05	0.000282	CcSEcCtD
Clomifene—Urticaria—Prednisone—psoriasis	5.62e-05	0.000281	CcSEcCtD
Clomifene—Headache—Triamcinolone—psoriasis	5.61e-05	0.00028	CcSEcCtD
Clomifene—Body temperature increased—Prednisone—psoriasis	5.6e-05	0.00028	CcSEcCtD
Clomifene—Diarrhoea—Betamethasone—psoriasis	5.56e-05	0.000278	CcSEcCtD
Clomifene—Diarrhoea—Dexamethasone—psoriasis	5.56e-05	0.000278	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	5.54e-05	0.00113	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL6—psoriasis	5.47e-05	0.00111	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—NDUFA5—psoriasis	5.47e-05	0.00111	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	5.47e-05	0.00111	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Methotrexate—psoriasis	5.39e-05	0.000269	CcSEcCtD
Clomifene—Dizziness—Betamethasone—psoriasis	5.38e-05	0.000269	CcSEcCtD
Clomifene—Dizziness—Dexamethasone—psoriasis	5.38e-05	0.000269	CcSEcCtD
Clomifene—Insomnia—Methotrexate—psoriasis	5.35e-05	0.000267	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.35e-05	0.00109	CbGpPWpGaD
Clomifene—Nausea—Triamcinolone—psoriasis	5.32e-05	0.000266	CcSEcCtD
Clomifene—Paraesthesia—Methotrexate—psoriasis	5.31e-05	0.000265	CcSEcCtD
Clomifene—Dyspnoea—Methotrexate—psoriasis	5.27e-05	0.000264	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	5.26e-05	0.00107	CbGpPWpGaD
Clomifene—Hypersensitivity—Prednisone—psoriasis	5.22e-05	0.000261	CcSEcCtD
Clomifene—Vomiting—Dexamethasone—psoriasis	5.17e-05	0.000258	CcSEcCtD
Clomifene—Vomiting—Betamethasone—psoriasis	5.17e-05	0.000258	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.15e-05	0.00105	CbGpPWpGaD
Clomifene—Rash—Dexamethasone—psoriasis	5.13e-05	0.000256	CcSEcCtD
Clomifene—Rash—Betamethasone—psoriasis	5.13e-05	0.000256	CcSEcCtD
Clomifene—Dermatitis—Betamethasone—psoriasis	5.12e-05	0.000256	CcSEcCtD
Clomifene—Dermatitis—Dexamethasone—psoriasis	5.12e-05	0.000256	CcSEcCtD
Clomifene—Fatigue—Methotrexate—psoriasis	5.1e-05	0.000255	CcSEcCtD
Clomifene—Headache—Betamethasone—psoriasis	5.09e-05	0.000254	CcSEcCtD
Clomifene—Headache—Dexamethasone—psoriasis	5.09e-05	0.000254	CcSEcCtD
Clomifene—Asthenia—Prednisone—psoriasis	5.08e-05	0.000254	CcSEcCtD
Clomifene—Pain—Methotrexate—psoriasis	5.06e-05	0.000253	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—IFNG—psoriasis	5.03e-05	0.00102	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.02e-05	0.00102	CbGpPWpGaD
Clomifene—Pruritus—Prednisone—psoriasis	5.01e-05	0.00025	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	4.89e-05	0.000995	CbGpPWpGaD
Clomifene—Diarrhoea—Prednisone—psoriasis	4.84e-05	0.000242	CcSEcCtD
Clomifene—ESR1—Signaling Pathways—HCAR2—psoriasis	4.83e-05	0.000983	CbGpPWpGaD
Clomifene—Nausea—Betamethasone—psoriasis	4.83e-05	0.000241	CcSEcCtD
Clomifene—Nausea—Dexamethasone—psoriasis	4.83e-05	0.000241	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.77e-05	0.000971	CbGpPWpGaD
Clomifene—EBP—Metabolism—APOE—psoriasis	4.76e-05	0.000967	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	4.71e-05	0.000958	CbGpPWpGaD
Clomifene—Urticaria—Methotrexate—psoriasis	4.7e-05	0.000235	CcSEcCtD
Clomifene—Dizziness—Prednisone—psoriasis	4.68e-05	0.000234	CcSEcCtD
Clomifene—Body temperature increased—Methotrexate—psoriasis	4.68e-05	0.000234	CcSEcCtD
Clomifene—ABCB1—Allograft Rejection—CXCL8—psoriasis	4.68e-05	0.000951	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.67e-05	0.00095	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP2S1—psoriasis	4.65e-05	0.000945	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.62e-05	0.000939	CbGpPWpGaD
Clomifene—Vomiting—Prednisone—psoriasis	4.5e-05	0.000225	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	4.47e-05	0.000909	CbGpPWpGaD
Clomifene—Rash—Prednisone—psoriasis	4.46e-05	0.000223	CcSEcCtD
Clomifene—Dermatitis—Prednisone—psoriasis	4.46e-05	0.000223	CcSEcCtD
Clomifene—Headache—Prednisone—psoriasis	4.43e-05	0.000222	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.38e-05	0.000891	CbGpPWpGaD
Clomifene—Hypersensitivity—Methotrexate—psoriasis	4.36e-05	0.000218	CcSEcCtD
Clomifene—CYP2E1—Metabolism—NDUFA5—psoriasis	4.32e-05	0.000878	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CARM1—psoriasis	4.31e-05	0.000875	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.27e-05	0.000869	CbGpPWpGaD
Clomifene—Asthenia—Methotrexate—psoriasis	4.24e-05	0.000212	CcSEcCtD
Clomifene—Nausea—Prednisone—psoriasis	4.2e-05	0.00021	CcSEcCtD
Clomifene—ESR1—Signaling Pathways—TAGAP—psoriasis	4.19e-05	0.000852	CbGpPWpGaD
Clomifene—Pruritus—Methotrexate—psoriasis	4.19e-05	0.000209	CcSEcCtD
Clomifene—EBP—Metabolism—PPARG—psoriasis	4.14e-05	0.000842	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NDUFA5—psoriasis	4.07e-05	0.000828	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—VDR—psoriasis	4.07e-05	0.000828	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.05e-05	0.000824	CbGpPWpGaD
Clomifene—Diarrhoea—Methotrexate—psoriasis	4.05e-05	0.000202	CcSEcCtD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.02e-05	0.000818	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4e-05	0.000814	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4e-05	0.000814	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	3.97e-05	0.000807	CbGpPWpGaD
Clomifene—Dizziness—Methotrexate—psoriasis	3.91e-05	0.000196	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.9e-05	0.000793	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.85e-05	0.000783	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.8e-05	0.000772	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.8e-05	0.000772	CbGpPWpGaD
Clomifene—Vomiting—Methotrexate—psoriasis	3.76e-05	0.000188	CcSEcCtD
Clomifene—Rash—Methotrexate—psoriasis	3.73e-05	0.000186	CcSEcCtD
Clomifene—Dermatitis—Methotrexate—psoriasis	3.73e-05	0.000186	CcSEcCtD
Clomifene—Headache—Methotrexate—psoriasis	3.71e-05	0.000185	CcSEcCtD
Clomifene—CYP2E1—Metabolism—CYP2S1—psoriasis	3.67e-05	0.000747	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	3.61e-05	0.000733	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.54e-05	0.00072	CbGpPWpGaD
Clomifene—Nausea—Methotrexate—psoriasis	3.51e-05	0.000176	CcSEcCtD
Clomifene—CYP1A1—Metabolism—CYP2S1—psoriasis	3.46e-05	0.000704	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—CARM1—psoriasis	3.28e-05	0.000668	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—TNF—psoriasis	3.25e-05	0.000662	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NDUFA5—psoriasis	3.25e-05	0.000661	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.24e-05	0.000658	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	3.23e-05	0.000657	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.06e-05	0.000622	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.04e-05	0.000617	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.02e-05	0.000615	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—IL6—psoriasis	2.94e-05	0.000598	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.88e-05	0.000586	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CARM1—psoriasis	2.85e-05	0.00058	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—PPARG—psoriasis	2.84e-05	0.000577	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP2S1—psoriasis	2.77e-05	0.000562	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.68e-05	0.000544	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.67e-05	0.000542	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CAT—psoriasis	2.65e-05	0.000538	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NDUFA5—psoriasis	2.6e-05	0.000528	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCL20—psoriasis	2.51e-05	0.000511	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.000492	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CARM1—psoriasis	2.27e-05	0.000462	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP2S1—psoriasis	2.21e-05	0.000449	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.15e-05	0.000436	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.06e-05	0.00042	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—APOE—psoriasis	2.06e-05	0.000418	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NDUFA5—psoriasis	2e-05	0.000408	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—VDR—psoriasis	1.96e-05	0.000399	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.87e-05	0.000381	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.82e-05	0.000369	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CARM1—psoriasis	1.79e-05	0.000365	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PPARG—psoriasis	1.79e-05	0.000364	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CAT—psoriasis	1.75e-05	0.000357	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CYP2S1—psoriasis	1.7e-05	0.000347	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CARM1—psoriasis	1.69e-05	0.000344	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.61e-05	0.000327	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-05	0.000321	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.42e-05	0.000288	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CAT—psoriasis	1.4e-05	0.000284	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SOCS1—psoriasis	1.38e-05	0.000281	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARG—psoriasis	1.37e-05	0.000278	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—APOE—psoriasis	1.36e-05	0.000277	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CARM1—psoriasis	1.35e-05	0.000275	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARG—psoriasis	1.19e-05	0.000241	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000235	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CAT—psoriasis	1.1e-05	0.000224	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—APOE—psoriasis	1.09e-05	0.000221	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CARM1—psoriasis	1.08e-05	0.000219	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CAT—psoriasis	1.04e-05	0.000212	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APOE—psoriasis	1.02e-05	0.000207	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—LEP—psoriasis	1.02e-05	0.000207	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000205	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NFKBIA—psoriasis	9.51e-06	0.000193	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARG—psoriasis	9.45e-06	0.000192	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—APOE—psoriasis	8.57e-06	0.000174	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CARM1—psoriasis	8.32e-06	0.000169	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CAT—psoriasis	8.31e-06	0.000169	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—APOE—psoriasis	8.08e-06	0.000164	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TYK2—psoriasis	7.79e-06	0.000158	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARG—psoriasis	7.47e-06	0.000152	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARG—psoriasis	7.04e-06	0.000143	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL8—psoriasis	6.78e-06	0.000138	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CAT—psoriasis	6.63e-06	0.000135	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—APOE—psoriasis	6.46e-06	0.000131	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—JUN—psoriasis	6.3e-06	0.000128	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NFKB1—psoriasis	6.07e-06	0.000123	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARG—psoriasis	5.62e-06	0.000114	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—psoriasis	5.51e-06	0.000112	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—STAT3—psoriasis	5.45e-06	0.000111	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—APOE—psoriasis	5.15e-06	0.000105	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CAT—psoriasis	5.12e-06	0.000104	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARG—psoriasis	4.49e-06	9.13e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—psoriasis	4.16e-06	8.46e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—APOE—psoriasis	3.98e-06	8.09e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL6—psoriasis	3.81e-06	7.74e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARG—psoriasis	3.47e-06	7.04e-05	CbGpPWpGaD
